Hyphens Pharma International Ltd
SGX:1J5
Cash Flow Statement
Cash Flow Statement
Hyphens Pharma International Ltd
Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||||||||||||
Net Income |
7
|
7
|
7
|
6
|
7
|
6
|
6
|
7
|
8
|
9
|
9
|
8
|
7
|
7
|
8
|
11
|
14
|
11
|
11
|
14
|
|
Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
|
Other Non-Cash Items |
0
|
0
|
1
|
1
|
2
|
2
|
1
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(0)
|
|
Cash Taxes Paid |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
3
|
3
|
2
|
|
Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Change in Working Capital |
(4)
|
(6)
|
(4)
|
(6)
|
(2)
|
2
|
3
|
(0)
|
(0)
|
(2)
|
(4)
|
(6)
|
(5)
|
(3)
|
(5)
|
(6)
|
(0)
|
(2)
|
(7)
|
(14)
|
|
Cash from Operating Activities |
4
N/A
|
3
-39%
|
5
+84%
|
2
-55%
|
8
+246%
|
11
+49%
|
12
+3%
|
10
-18%
|
9
-1%
|
9
-3%
|
7
-23%
|
4
-43%
|
4
+2%
|
7
+64%
|
6
-11%
|
8
+32%
|
17
+112%
|
11
-35%
|
6
-48%
|
3
-47%
|
|
Investing Cash Flow | |||||||||||||||||||||
Capital Expenditures |
(0)
|
(0)
|
(1)
|
(2)
|
(3)
|
(4)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
|
Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(14)
|
(14)
|
0
|
0
|
(0)
|
(0)
|
|
Cash from Investing Activities |
(0)
N/A
|
(0)
-17%
|
(1)
-400%
|
(2)
-144%
|
(3)
-44%
|
(4)
-7%
|
(3)
+29%
|
(1)
+44%
|
(0)
+68%
|
(1)
-70%
|
(1)
-58%
|
(1)
+10%
|
(1)
+7%
|
(0)
+68%
|
(15)
-4 518%
|
(15)
0%
|
(1)
+93%
|
(2)
-62%
|
(1)
+9%
|
(3)
-91%
|
|
Financing Cash Flow | |||||||||||||||||||||
Net Issuance of Common Stock |
0
|
0
|
16
|
0
|
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
Net Issuance of Debt |
(3)
|
(4)
|
(0)
|
(1)
|
(1)
|
(2)
|
(6)
|
(2)
|
(3)
|
(1)
|
(0)
|
(1)
|
1
|
0
|
3
|
1
|
(3)
|
(1)
|
(2)
|
(1)
|
|
Cash Paid for Dividends |
0
|
(1)
|
(4)
|
0
|
(7)
|
0
|
1
|
(2)
|
(2)
|
0
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(15)
|
(14)
|
|
Other |
(1)
|
(0)
|
(2)
|
(2)
|
(2)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
6
|
6
|
(0)
|
(0)
|
(0)
|
|
Cash from Financing Activities |
(4)
N/A
|
(5)
-5%
|
9
N/A
|
9
-1%
|
6
-38%
|
5
-17%
|
(11)
N/A
|
(8)
+31%
|
(5)
+34%
|
(3)
+47%
|
(3)
-25%
|
(4)
-13%
|
(2)
+55%
|
(2)
+9%
|
1
N/A
|
4
+452%
|
1
-74%
|
(5)
N/A
|
(17)
-277%
|
(15)
+11%
|
|
Change in Cash | |||||||||||||||||||||
Net Change in Cash |
(0)
N/A
|
(2)
-579%
|
13
N/A
|
9
-31%
|
10
+9%
|
13
+25%
|
(2)
N/A
|
0
N/A
|
4
+2 066%
|
6
+48%
|
2
-57%
|
(1)
N/A
|
1
N/A
|
5
+255%
|
(8)
N/A
|
(2)
+69%
|
17
N/A
|
5
-72%
|
(13)
N/A
|
(15)
-16%
|
|
Free Cash Flow | |||||||||||||||||||||
Free Cash Flow |
4
N/A
|
2
-41%
|
4
+60%
|
(0)
N/A
|
4
N/A
|
8
+84%
|
9
+18%
|
8
-12%
|
9
+11%
|
8
-7%
|
6
-30%
|
3
-52%
|
3
+6%
|
6
+115%
|
5
-17%
|
7
+32%
|
16
+126%
|
9
-42%
|
4
-51%
|
1
-88%
|